Paradoxical effect of estradiol: It can block its own bioformation in human breast cancer cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 78, Issue 1, 2001, Pages 21-24

  Pasqualini, J R ^a   Chetrite, G ^a  

^a Hormones and Cancer Research Unit   (France)

Author keywords

Breast cancer cell lines; Estradiol; Estrone sulfatase

Indexed keywords

ENZYME INHIBITOR; ESTRADIOL; ESTRONE SULFATE; STEROID; SULFATASE; TRITIUM;

ARTICLE; BIOTRANSFORMATION; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER MORTALITY; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; ESTROGEN SYNTHESIS; ESTROGEN THERAPY; FETAL CALF SERUM; HORMONE ACTION; HUMAN; HUMAN CELL; INCUBATION TIME; POSTMENOPAUSE;

BREAST NEOPLASMS; CULTURE MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; HUMANS; INHIBITORY CONCENTRATION 50; SULFATASES; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0034877018     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(01)00080-2     Document Type: Article

References (28)

1. The selective estrogen enzyme modulator (SEEM) in breast cancer
2. The role of hormones in the development of human breast cancer
3. Estrogens as a cause of human cancer: The Richard and Hinda Rosenthal Foundation Award Lecture
4. Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue
5. Aromatase, 17β-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women
6. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer
7. Aromatization of androgens by human breast cancer
8. The conversion of androstenedione to estrone, estradiol, and testosterone in breast tissue
9. Steroid sulfatase activities in human breast tumors
10. Effects of plasma estrogen sulfates in mammary cancer cells
11. Estrogen sulfates: Biological and ultrastructural responses and metabolism in MCF-7 human breast cancer cells
12. The hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate by MCF-7 human breast cancer cells
13. Importance of estrogen sulfates in breast cancer
14. Estradiol 17β-dehydrogenase and estradiol binding in human mammary tumors
15. 3H-oestradiol by normal breast and breast tumour tissues in post-menopausal women
16. In situ estrogen production via the estrone sulfatase pathway in breast tumors: Relative importance versus the aromatase pathway
17. Effect of nomegestrol acetate on estrone-sulfatase and 17β-hydroxysteroid dehydrogenase activities in human breast cancer cells
18. Control of sulfatase and sulfotransferase activities by medrogestone in the hormone-dependent MCF-7 and T-47D human breast cancer cell lines
19. Effect of tibolone (Org OD14) and its metabolites on estrone sulphatase activity in MCF-7 and T-47D mammary cancer cells
20. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid
21. Inhibition of steroid sulphatase activity by tricyclic coumarin sulphamates
22. Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: Inhibition by novel non-steroidal steroid sulfatase inhibitors
23. The relationship between breast cancer survival and prior post-menopausal estrogen use
24. Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States
25. Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy-long-term follow-up of a Swedish cohort
26. Impact of menopausal hormone-replacement therapy on clinical and laboratory characteristics of breast cancer
27. Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients
28. Potential benefits of estrogens and progestogens on breast cancer